Showing 11-20 of 190 results for "".
- Rubedo Reports Early Clinical Activity for GPX4 Modulator RLS-1496 in Actinic Keratosishttps://practicaldermatology.com/news/rubedo-reports-early-clinical-activity-for-gpx4-modulator-rls-1496-in-actinic-keratosis/2487263/Rubedo Life Sciences announced preliminary findings from a Phase 1b/2a trial evaluating topical RLS-1496 1% cream in adults with actinic keratosis (AK), reporting reductions in lesion counts alongside favorable tolerability data. The interim findings were presented at the RBC Capital Markets Glob
- Study: 60% Lesion Clearance in Actinic Keratosis Patients Using Topical Bimiralisib Gelhttps://practicaldermatology.com/news/study-60-lesion-clearance-in-actinic-keratosis-patients-using-topical-bimiralisib-gel/2471542/Newly presented interim results from a phase 2 clinical trial evaluating bimiralisib topical gel (2%) saw more than half of patients with actinic keratosis achieving complete or partial lesion clearance. Bimiralisib, a pan-PI3
- Survey Shows Low Awareness, High Risk of Actinic Keratosis from Sun Exposurehttps://practicaldermatology.com/news/survey-shows-low-awareness-high-risk-actinic-keratosis-sun-exposure/2463197/A recent survey conducted by Almirall showed gaps in public awareness about actinic keratosis (AK) and the associated risks of sun exposure. The survey, which included more than 2,500 participants aged 35 and older from Spain, Germany, Italy, the United Kingdom, and the United States, rev
A Practical Approach: Field Treatment of AKs with PDT
https://practicaldermatology.com/issues/supplements/a-practical-approach-field-treatment-of-aks-with-pdt/20431/Why it's essential to treat visible and invisible actinic keratosis lesions and how PDT fits into the treatment armamentarium.Optimizing Patient Experience With Photodynamic Therapy
https://practicaldermatology.com/issues/supplements/optimizing-patient-experience-with-photodynamic-therapy/23972/As diagnoses of actinic keratosis rise, so has access to photodynamic therapy—making clear, compassionate communication a critical component of overall patient experience.- Report: 5-FU and Imiquimod Combo May Offer Enhanced Actinic Keratosis Clearancehttps://practicaldermatology.com/news/report-5-fu-and-imiquimod-combo-may-offer-enhanced-actinic-keratosis-clearance/2474234/Combining 5-fluorouracil (5-FU) and imiquimod may enhance therapeutic efficacy for actinic keratoses (AK), according to emerging data. "To date, the combination of 5-FU and imiquimod, 2 of the most used monotherapies, remain
- SKNV Secures Exclusive Rights to Patented 5-FU/Calcipotriene Combination for Actinic Keratosishttps://practicaldermatology.com/news/sknv-secures-exclusive-rights-to-patented-5-fucalcipotriene-combination-for-actinic-keratosis/2487883/SKNV has obtained exclusive commercialization rights under a sublicense to a patent covering the combination of fluorouracil (5-FU) and calcipotriene, according to an announcement. The patented combination is currently avai
AK Pearls: Managing Treatment Reactions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-pearls-managing-treatment-reactions/18741/Dr. Bhatia shares pearls for managing side effects and reactions to actinic keratosis treatment drugs. There are many adjunctive therapies to counter these reactions from emollients to barrier repair cream to time and some TLC for patients.AK Treatment Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-treatment-pearls/19731/Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-Cutaneous Oncology in 2024
https://practicaldermatology.com/conferences/maui-derm-2024/cutaneous-oncology-in-2024/20266/Resident Of Distinction Award-winner Banu Farabi, MD, a PGY-3 resident at New York Medical College, talks about a review she attended highlighting the latest therapeutic approaches to treating conditions such as actinic keratosis and several different types of skin cancer, as well as an overview of